Management of Pre-eclampsia Post Cesarean Section Using Labetalol Infusion

Immediate Management Goals

• The immediate goal is to decrease mean blood pressure by 15-25% with target systolic blood pressure of 140-150 mmHg and diastolic blood pressure of 90-100 mmHg, as recommended by the European Society of Cardiology 1, 3
• Continuous monitoring of maternal blood pressure and fetal heart rate is essential during treatment, according to the European Heart Journal 2

Labetalol IV Administration Protocol

• The maximum cumulative dose of labetalol should not exceed 300 mg in 24 hours, as stated by the European Heart Journal 2

Important Safety Considerations

• To prevent fetal bradycardia, the cumulative dose of labetalol should not exceed 800 mg/24 hours, as recommended by the European Heart Journal 2, 4
• Monitor for signs of maternal hypotension which can lead to fetal distress, according to the European Society of Cardiology 1
• Caution is required in patients with asthma, heart block, or heart failure, as stated by the European Society of Cardiology 1

Alternative Medications

• If labetalol is contraindicated or ineffective, alternatives include IV nicardipine (5 mg/h, increasing by 2.5 mg/h every 5-15 min to maximum 15 mg/h), as recommended by the European Society of Cardiology 1, 5
• IV urapidil (bolus 12.5-25 mg, maintain 5-40 mg/h) can be considered, according to the European Heart Journal 1, 4
• Oral nifedipine (10-20 mg) can be considered if IV access is not available, but caution is needed when combined with magnesium sulfate due to risk of hypotension, as stated by the European Society of Cardiology 1, 3

Post-Treatment Monitoring

• All women with hypertension in pregnancy should have BP and urine checked at 6 weeks postpartum, as recommended by the European Heart Journal 6
• Persistent hypertension should be confirmed by 24-hour ambulatory monitoring, according to the European Heart Journal 6
• Women with persisting hypertension or proteinuria 6 weeks after delivery should be referred to a specialist, as stated by the European Heart Journal 6

Common Pitfalls to Avoid

• Avoid sodium nitroprusside due to risk of fetal cyanide poisoning, as recommended by the European Society of Cardiology 1, 2
• Short-acting oral nifedipine should be avoided when combined with magnesium sulfate due to risk of profound hypotension, according to the European Society of Cardiology 1, 3
• Avoid hydralazine as it has been associated with adverse perinatal outcomes, as stated by the European Heart Journal 2, 4